In this issue:
Treatment according to BRCA1/2 & HRD in breast/epithelial ovarian cancer
LETSGO: a follow-up model for gynaecological cancer survivors
A multidisciplinary gynaecological oncology clinic in Botswana
BRCA1/RAD51C methylation & HRD status in HGSOC
Bevacizumab + neoadjuvant chemotherapy in HGSOC after failure of early interval debulking surgery
Recurrence in early-stage cervical cancer after surgery
Fertility-sparing surgery & survival in epithelial ovarian cancer
Frailty scores & minimally invasive surgery outcomes in endometrial cancer
Radiotherapy ± chemotherapy in FIGO 2023 stage IIC endometrial cancer
PROs from ENGOT-cx11/GOG-3047/KEYNOTE-A18
Please login below to download this issue (PDF)